Mayim Bialik, an actress, author, and neuroscientist, who became a fan-favorite on the hit CBS show The Big Bang Theory as Sheldon's quirky love interest, is starring in a sitcom of her own again. 

The show, which premiered in January and titled Call Me Kat, is about a woman who uses her life savings to open a cat cafe in Louisville, Ky. Jim Parsons, who starred opposite Bialik in The Big Bang Theory as the highly intelligent but often irritating Sheldon, is producing the show adapted from the British sitcom Miranda by Miranda Hart.

"He said 'if anyone can pull off annoying but also adorable, I think it's you," Bialik told Cheddar. 

In the grand-old tradition of adapting British comedies, the two shows will share more in spirit than in specifics, but both concern a single woman looking for love and employment. What's unique to the American version is the decision to base the show in a cat cafe. 

Luckily for Bialik, she's a cat owner herself. 

"It's really awesome that I get to play with cats all day at work, and come home and then deal with my own cats who definitely smell the other cats on me," she said.

A stylistic choice that was carried over from Miranda is that Bialik's character will break the fourth wall throughout the show. 

"Kat is a character who's alone a lot and tries not to be lonely, so the audience is kind of in on what's going on in her head," Bialik said. 

In addition, the cast takes a bow at the end of each episode, which Bialik said has been divisive. 

"You don't have to love it, but if you don't, it's not our fault. It's based on Miranda," she said.

The neuroscientist also took a moment to talk about the world outside the silver screen.  

Bialik made headlines back in October for posting a video on YouTube clarifying that she was not an anti-vaxxer. She said misinformation had spread about her because her newly-born children were not vaccinated on a regular schedule. 

"Obviously my children are vaccinated," she said. "We are a family that supports the vaccine program for this virus." 

However, she noted that she was a skeptical person in general and pointed out that the long-term effects of COVID vaccines are still unknown. Nonetheless, she said she got the vaccine in order to reach herd immunity as soon as possible. 

"I got the vaccine, and that's something that I decided to share about because there's been a lot of misinformation about me." 

Share:
More In Culture
The State of Lactation Support in the U.S.
Sarah Kellogg Neff, CEO of The Lactation Network, joins ChedHER to discuss how they are expanding access to lactation support for families nationwide, and some of the struggles new families face during the fourth trimester.
American Gaming Association Says 45 Million Americans to Wager $3.1 Billion on March Madness
March Nadness is officially underway, and betting on this year's tournament has the potential to reach record levels. About 45 million Americans are expected to wager a total of $3.1 billion on just the men's tournament alone, according to a new survey from the American Gaming Association. Prince Grimes, Senior Writer for USA Today's sports betting media property, BetFTW, joins Cheddar News' Closing Bell to discuss how betting could play into this year's tournament and other storylines surrounding March Madness.
Medical Cannabis Company Akanda Sees Stock Surge in March's First IPO
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Akeneo CEO on $135 Million Fundraise to Redefine Product Management
Software company Akeneo CEO Fred De Gombert joined Closing Bell to discuss its recently closed Series D funding round raising $135 million in its quest to redefine product information management. De Gombert said the company is set out to improve the product information category by harnessing the power of data, which comes at a time where customer behavior has shifted in the pandemic era. "We are more and more demanding as consumers when we are shopping online or even offline. We are looking for more and more information," De Gombert said.
Colossal CEO Says Its About Saving Biodiversity, Not Just Extinct Woolly Mammoth
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Load More